Laurus Labs

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.

Our mission is to create value for our customers and society by discovering, developing, and delivering innovative products and services that support healthier, more sustainable lifestyles.

Our vision is to become the largest and most trusted life sciences and clean energy chemicals company in the world, unlocking the potential of science to change the future.

Laurus Labs has been recognized for its commitment to innovation and quality, having received multiple awards, including the Edison Award for breakthrough environmental technology, the Frost & Sullivan Entrepreneur of the Year award, and the American Chemical Society’s Green Chemistry Award.